Funder
Japan Society for the Promotion of Science
Japan Sciety for the Promotion of Science
The Mochida Memorial Foundation for Medical and Pharmaceutical Research
The Research Foundation for Pharmaceutical Sciences
the U.S. National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference40 articles.
1. Zeng Z, Hill-Yardin EL, Williams D, O'Brien T, Serelis A, French CR. Effect of phenytoin on sodium conductances in rat hippocampal CA1 pyramidal neurons. J Neurophysiol. 2016;116(4):1924–36.
2. Carter CH. Use of parenteral diphenylhydantoin (dilantin) sodium in control of status epilepticus. AMA Arch Neurol Psychiatry. 1958;79(2):136–7.
3. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–9.
4. Bajpai M, Roskos LK, Shen DD, Levy RH. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab Dispos. 1996;24(12):1401–3.
5. Fohner AE, Ranatunga DK, Thai KK, Lawson BL, Risch N, Oni-Orisan A, et al. Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system. Pharmacogenet Genomics. 2019;29(8):192–9.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献